Back to today’s briefing

Story perspectives

Biotech Firms Lure Talent with Stock Options and Grants

2/6/2025

28 5

Summary

Story summary

Arcutis Biotherapeutics has welcomed eight new employees with a generous grant of 62,000 restricted stock units, set to vest over four years. Meanwhile, Akebia Therapeutics has awarded 130,763 stock options to seven newcomers, and Cartesian Therapeutics has offered 168,360 options to five new hires, all aimed at attracting top talent.

History

Historical Context

The recent hiring incentives by Arcutis Biotherapeutics, Akebia Therapeutics, and Cartesian Therapeutics echo the post-2008 financial crisis trend where companies used stock options to attract talent amid economic uncertainty. This strategy aims to bolster employee retention and align interests, reflecting historical responses to market volatility.

1 of 2

Story summary

Arcutis Biotherapeutics has welcomed eight new employees with a generous grant of 62,000 restricted stock units, set to vest over four years. Meanwhile, Akebia Therapeutics has awarded 130,763 stock options to seven newcomers, and Cartesian Therapeutics has offered 168,360 options to five new hires, all aimed at attracting top talent.

1 / 2